Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Assets: 2009-2025

Historic Assets for Aytu Biopharma (AYTU) over the last 16 years, with Sep 2025 value amounting to $125.0 million.

  • Aytu Biopharma's Assets rose 7.91% to $125.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.0 million, marking a year-over-year increase of 7.91%. This contributed to the annual value of $124.2 million for FY2025, which is 5.15% up from last year.
  • Aytu Biopharma's Assets amounted to $125.0 million in Q3 2025, which was up 0.65% from $124.2 million recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Assets ranged from a high of $271.6 million in Q1 2021 and a low of $115.8 million during Q3 2024.
  • For the 3-year period, Aytu Biopharma's Assets averaged around $127.3 million, with its median value being $125.0 million (2025).
  • Per our database at Business Quant, Aytu Biopharma's Assets skyrocketed by 73.31% in 2021 and then slumped by 48.20% in 2022.
  • Aytu Biopharma's Assets (Quarterly) stood at $223.8 million in 2021, then slumped by 36.81% to $141.4 million in 2022, then fell by 7.20% to $131.2 million in 2023, then fell by 11.45% to $116.2 million in 2024, then increased by 7.91% to $125.0 million in 2025.
  • Its last three reported values are $125.0 million in Q3 2025, $124.2 million for Q2 2025, and $124.2 million during Q1 2025.